Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock, returning 9,091.6%.

ASSET	% RETURN
Regencell Bioscience (RGC)	9,091.62%
CannBioRx Life Sciences (ATNFW)	4,287.76%
DeFi Development (DFDV)	2,231.7%
WW International, Inc Common Stock (WW)	2,218.32%
HCM II Acquisition (HONDW)	2,098.28%
Blue Gold Limited Warrant (BGLWW)	1,750%
Oncology Institute (TOIIW)	1,460.71%
Zepp Health (ZEPP)	1,411.15%
BT Brands Inc Warrant (BTBDW)	1,340.53%
Diginex Limited Ordinary Shares (DGNX)	1,263.15%
FiEE (FIEE)	1,207.34%
Protagenic Therapeutics (PTIXW)	1,115.38%
CEA Industries (VAPEW)	1,108.05%
CEA Industries (BNCWW)	1,097.99%
K Wave Media (KWMWW)	1,064.08%
Rich Sparkle Holdings Limited Ordinary Shares (ANPA)	1,058.33%
USA Rare Earth (USARW)	1,048%
Oncology Institute (TOI)	1,033.99%
Abivax SA American Depositary Shares (ABVX)	969.89%
Newegg Commerce (NEGG)	962.5%
Webull Corporation Warrants (BULLW)	930.53%
Asset Entities Inc Class B Common Stock (ASST)	860%
Global Interactive Technologies (GITS)	846.06%
Anbio Biotechnology Class A Ordinary Shares (NNNN)	834.03%
Above Food Ingredients Inc Warrants (ABVEW)	768.18%